UVV

Universal Corporation 10-K Summary: Fiscal Year Ended June 30, 1996

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended June 30, 1996, for Universal Corporation, the world's largest independent leaf tobacco merchant. The Company operates in three primary segments: Tobacco (71% of revenue, 83% of operating profit), Agri-products (13% of revenue), and Lumber and Building Products (16% of revenue). Universal does not manufacture consumer tobacco products but provides processing, storage, and financing services to manufacturers globally. The Company employed approximately 30,000 people worldwide during the fiscal year.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenues increased 8.8% ($289 million) driven primarily by a $228 million increase in tobacco revenues due to improved market conditions, higher volumes, and price increases. Lumber and building products revenue rose $62 million, aided by a stronger Dutch guilder and the full-year inclusion of the Heuvelman acquisition.
• Profitability Surge: Net income nearly tripled to $72.2 million from $25.6 million. Tobacco operating profits increased $66 million to $168 million. This improvement was bolstered by the absence of the $15.6 million restructuring charge and $10.7 million in inventory write-downs that impacted fiscal 1995 results.
• Cost Management: Selling, General, and Administrative (SG&A) expenses rose only 4% ($12 million), largely due to the Heuvelman acquisition, while interest expense decreased slightly due to lower average borrowing rates.
• Liquidity: Working capital increased by approximately $35 million. The Company issued $100 million in 10-year notes in February 1996 to reduce short-term debt.

Outlook, Risks, and Management Commentary

• Market Outlook: Management views the outlook for fiscal 1997 as favorable, citing a move toward balance in worldwide tobacco supply and demand. Demand for American blend cigarettes is growing in developing markets (Asia, Eastern Europe).
• Regulatory Risks: Significant risks remain regarding anti-smoking legislation, including potential FDA regulation of nicotine, increased excise taxes, and restrictions on advertising. Litigation against cigarette manufacturers regarding health effects and Medicaid costs continues, with uncertain outcomes for the Company.
• Operational Risks: The Company faces exposure to political instability, currency fluctuations, and expropriation in foreign markets. A material portion of tobacco business depends on a few customers; Philip Morris accounted for over 10% of consolidated revenues in 1996.
• Unusual Items: Fiscal 1996 included a $1.4 million recovery of receivables from the Iraqi State Tobacco Monopoly, recorded as an extraordinary item. The Company also implemented a restructuring plan initiated in 1995, with remaining actions expected to be insignificant.

Investor Verification Checklist

• Customer Concentration: Verify the stability of relationships with top customers, specifically Philip Morris, which represents a significant revenue portion.
• Regulatory Environment: Monitor developments in U.S. and international tobacco regulation, including FDA proposals and state-level litigation, which could materially impact operating income.
• Foreign Operations: Assess the impact of currency fluctuations and political risks in key sourcing regions like Brazil, Africa, and Eastern Europe.
• Inventory Valuation: Review tobacco inventory levels and potential for future write-downs given the historical volatility in leaf prices and supply/demand imbalances.
• Debt Structure: Confirm the Company's ability to service its debt, noting the recent shift from short-term to long-term financing and the $1.7 billion in uncommitted lines of credit.